Summary of WHO Guidelines on Postpartum Hemorrhage (PPH)
This article details new guidelines from the World Health Institution (WHO), the International Federation of Gynecology and Obstetrics (FIGO), and the International Confederation of Midwives (ICM) aimed at preventing, diagnosing, and treating Postpartum Hemorrhage (PPH) – excessive bleeding after childbirth.PPH is a leading cause of maternal mortality globally, causing nearly 45,000 deaths annually and leading to notable health impacts even when not fatal.
Key takeaways:
* Earlier Detection is Crucial: The guidelines lower the diagnostic threshold for PPH from 500mL to 300mL of blood loss when accompanied by abnormal vital signs. This emphasizes the need for rapid response, as PPH can escalate quickly.
* Improved Diagnostic Tools: Clinicians are advised to use calibrated drapes to accurately measure blood loss.
* MOTIVE Bundle for Immediate Action: Upon diagnosis, the MOTIVE bundle should be instantly implemented:
* Massage of the uterus
* Oxytocic drugs
* Tranexamic acid (TXA)
* Intravenous fluids
* Vaginal and genital tract examination
* Escalation of care if bleeding persists
* Prevention is Key: The guidelines highlight the importance of addressing risk factors like anemia through antenatal and postnatal care, including iron and folate supplementation and, when necessary, intravenous iron transfusions.
* Focus on Resource-Limited Settings: The guidelines are designed to be impactful even in areas with limited healthcare resources,aiming to improve survival rates and ensure women can safely return home after childbirth.
In essence, the new guidelines represent a shift towards proactive readiness, early recognition, and rapid response to PPH, with the goal of substantially reducing maternal mortality and morbidity.
